CAS 1352610-25-3

Formula: C22H19ClFN7

InChI: InChI=1S/C22H18FN7.ClH/c1-14-5-4-8-18(27-14)22-21(15-9-10-20-25-13-26-30(20)12-15)28-19(29-22)11-24-17-7-3-2-6-16(17)23;/h2-10,12-13,24H,11H2,1H3,(H,28,29);1H

InChI key: UDRJLVATGDHMJM-UHFFFAOYSA-N

SMILES: CC1=NC(=CC=C1)C2=C(N=C(N2)CNC3=CC=CC=C3F)C4=CN5C(=NC=N5)C=C4.Cl

Vactosertib Hydrochloride

CAS: 1352610-25-3

Vactosertib Hydrochloride

Formula: C₂₂H₁₉ClFN₇

Purity: 98%

Molecular weight: 435.89

Ref: 54-BUP21246

Vactosertib HCl

CAS: 1352610-25-3

Formula: C₂₂H₁₉ClFN₇

Purity: 98%

Molecular weight: 435.8846

Ref: IN-DA01EO6K

Vactosertib Hydrochloride

CAS: 1352610-25-3

Vactosertib Hydrochloride (EW-7197 Hydrochloride) is an ALK5 inhibitor, a TGF-β receptor I inhibitor with antimetastatic and anticancer effects.

Formula: C₂₂H₁₉ClFN₇

Purity: 98.03%

Color and Shape: White Solid

Molecular weight: 435.885

Ref: TM-T15262

Vactosertib HCl

CAS: 1352610-25-3

N-((4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline hydrochloride

Formula: C₂₂H₁₉ClFN₇

Purity: 98%

Molecular weight: 435.88

Ref: IN-DG00773610

Vactosertib Hydrochloride

CAS: 1352610-25-3

Vactosertib hydrochloride is a small molecule that binds to the receptor tyrosine kinase AXL and inhibits its activity. It has been shown to inhibit the proliferation of cancer cells in vitro. Vactosertib hydrochloride can also be used as a research tool for studying protein interactions, ion channels, and cell biology.

Formula: C₂₂H₁₉ClFN₇

Purity: Min. 95%

Molecular weight: 435.88 g/mol

Ref: 3D-CEC61025